Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples